Calendar Akero Therapeutics, Inc.

Equities

AKRO

US00973Y1082

Real-time Estimate Cboe BZX 03:38:53 2024-03-28 pm EDT 5-day change 1st Jan Change
25.27 USD +3.35% Intraday chart for Akero Therapeutics, Inc. -2.62% +8.18%

Chart calendar Akero Therapeutics, Inc.

ab6c601c98552c1469e5b0.1bf_fKL8WSSRdlb2R4kLbaNzG037wBAfAJZ-irhVr3E.m4-pRey2bEPIL2KUA-ZsG5ogbGCsjVFNMN9N68gA1wLs0rsY06QrUMM_bg~192af5a38b8d90f71a661edbc29e4c6c

Upcoming events on Akero Therapeutics, Inc.

2024-05-13 Q1 2024 Earnings Release (Projected)
2024-08-12 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-05-19 Q1 2025 Earnings Release (Projected)

Past events on Akero Therapeutics, Inc.

2024-03-04 08:00 am Efruxifermin Phase 2b HARMONY Study Results Call
2024-02-29 07:00 am Q4 2023 Earnings Release
2024-01-08 12:45 pm JPMorgan Healthcare Conference
2023-11-29 07:30 am Evercore ISI HealthCONx Conference - Fireside Chat
2023-11-15 12:00 pm Jefferies London Healthcare Conference - Fireside Chat
2023-11-13 03:15 pm American Association for the Study of Liver Diseases Conference - Abstract Number: 5005
2023-11-13 01:00 pm American Association for the Study of Liver Diseases Conference - Abstract Number: 48626
2023-11-13 07:00 am Q3 2023 Earnings Release
2023-10-24 12:00 pm H.C. Wainwright NASH Investor Conference
2023-10-10 08:00 am Efruxifermin Phase 2b SYMMETRY Study Results Call
2023-09-13 09:00 am H.C. Wainwright Global Investment Conference
2023-09-12 04:55 pm Morgan Stanley Global Healthcare Conference
2023-08-11 06:00 am Q2 2023 Earnings Release
2023-06-23 09:00 am Annual General Meeting
2023-06-07 10:30 am Jefferies Global Healthcare Conference
2023-06-05 08:00 am SYMMETRY Cohort D Phase 2b Trial Results Call
2023-05-15 07:00 am Q1 2023 Earnings Release
2023-03-17 07:00 am Q4 2022 Earnings Release
2023-01-10 01:30 pm JP Morgan Healthcare Conference
2022-11-29 12:10 pm Evercore ISI HealthCONx Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Million USD
Released
Forecast
Spread
-45,7
-45,4
-0.58%
-74,1
-67,6
-9.59%
-101
-97,0
-3.96%
-115
-123
6.44%
-173
-156
-10.52%

-249

EBIT
Million USD
Released
Forecast
Spread
-45,7
-45,2
-0.96%
-80,2
-70,2
-14.17%
-101
-96,9
-4.15%
-115
-125
8.11%
-173
-160
-7.93%

-240

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-43,8
-45,1
2.98%
-79,2
-69,2
-14.42%
-101
-96,8
-4.11%
-112
-125
10.33%
-152
-148
-2.85%

-230

Net income
Million USD
Released
Forecast
Spread
-43,8
-45,6
4.11%
-79,2
-68,6
-15.46%
-101
-96,5
-4.47%
-112
-125
10.04%
-152
-147
-3.3%

-235

EPS
USD
Released
Forecast
Spread
-2,90
-2,83
-2.41%
-2,52
-2,20
-14.49%
-2,89
-2,76
-4.88%
-2,87
-3,22
10.73%
-2,89
-2,90
0.24%

-4,04

Announcement Date16/03/2016/03/2125/02/2217/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


0,00


0,00


0,00




EBITDA
Million USD
Released
Forecast
Spread
-32,4
-28,0
-15.63%
-26,0
-29,0
10.21%
-27,6


-36,1
-32,0
-12.75%
-25,4
-37,0
31.32%
-28,7
-28,0
-2.65%
-35,6
-33,0
-7.93%
-46,6
-40,0
-16.53%
-61,9
-43,0
-43.89%

-66,0


-71,0


-76,0


-81,0




EBIT
Million USD
Released
Forecast
Spread
-32,4
-28,1
-15.5%
-26,1
-28,2
7.76%
-27,6
-33,8
18.35%
-36,1
-30,4
-18.82%
-25,4
-35,9
29.15%
-28,8
-29,8
3.61%
-35,6
-32,1
-10.83%
-46,6
-37,0
-25.97%
-61,9
-48,3
-28.07%

-59,4


-59,6


-61,6


-67,7


-67,6

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-32,4
-28,5
-13.57%
-26,0
-29,3
11.02%
-27,4
-33,8
18.9%
-35,5
-30,8
-15.29%
-23,1
-36,0
35.87%
-25,8
-30,0
13.85%
-31,1
-32,2
3.52%
-39,7
-36,0
-10.14%
-55,2
-48,0
-14.98%

-54,5


-54,6


-57,3


-66,1




Net income
Million USD
Released
Forecast
Spread
-32,4
-28,1
-15.47%
-26,0
-28,2
7.83%
-27,4
-33,8
18.9%
-35,5
-30,3
-17.22%
-23,1
-35,6
35.3%
-25,8
-29,6
12.81%
-31,1
-32,2
3.52%
-39,7
-37,1
-6.77%
-55,2
-48,5
-13.89%

-56,5


-56,8


-58,9


-65,0


-68,9

EPS
USD
Released
Forecast
Spread
-0,93
-0,80
-16.21%
-0,74
-0,81
8.51%
-0,77
-0,90
14.58%
-0,92
-0,72
-27.83%
-0,49
-0,80
38.44%
-0,55
-0,67
18.15%
-0,60
-0,70
13.67%
-0,71
-0,68
-4.55%
-0,99
-0,87
-13.86%

-1,00


-1,00


-1,04


-1,15


-1,21

Announcement Date25/02/2206/05/2205/08/2204/11/2217/03/2315/05/2311/08/2313/11/2329/02/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise